BRCA1 and neoplasm: However, our own tumor-informed re-alignment and re-analysis found the TP53 G245D to be detectable in the cfDNA throughout this entire period, while we detected the BRCA1 N1521fs in cfDNA samples collected 2 months prior to its re-appearance in the vendor’s clinical reports (Fig. 1B).